Product Specialist – Metabolic, Qatar at Eli Lilly and Company

Doha, Doha, Qatar

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Qualified/licensed pharmacist (degree in Pharmacy is mandatory)
  • Driver’s License (mandatory)
  • Minimum of 2 years pharmaceutical sales experience
  • Qatar experience required
  • Experience in Diabetes is a plus
  • Experience in the CardioMetabolic Health Customer Engagement Environment (hosting/attending educational meetings and forming relationships) is ideal
  • Understanding of healthcare systems and patient flow in relevant market
  • Excellent planning and time management skills
  • Strong written and verbal communication skills
  • Strong analytical skills
  • Strong business acumen
  • Demonstrated leadership without authority
  • Demonstrated resilience in complex environments
  • Demonstrated high learning agility
  • Passion for pharmaceutical sales with proven record of accomplishments (previous sales achievements and awards)
  • Presentation skills
  • Ability to build and foster relationships
  • Strong customer focus and understanding of commercial environment
  • Diligent adherence to business integrity principles and ethics/compliance mindset
  • Proficient knowledge of anatomy, physiology, disease state, and current treatment options
  • Ability to work in a team and independently
  • Excellent interpersonal and communication skills
  • Embrace technology for strategic and data-driven decision making

Responsibilities

  • Understand the healthcare marketplace, payer environment, customer (account and stakeholder) priorities, patient/product/monetary flows, patient disease states and therapeutic options, and Lilly resources, processes, policies, and procedures
  • Analyse patient, product, and monetary flows; prioritize opportunities; build territory and account plans; and secure needed resources
  • Execute territory and account plans; achieve territory and account plan goals and complete actions on a timely basis; regularly assess and adjust territory and account plans as needed
  • Create superior customer interaction value by calling on General Practitioners, Specialists, and Pharmacies to promote products and achieve/exceed business objectives
  • Enhance customer experience by identifying critical needs, educating, and delivering optimal pharmaceutical-based healthcare solutions to achieve organizational goals

Skills

Pharmaceutical Sales
Diabetes
CardioMetabolic Health
Customer Engagement
Product Promotion
Pharmacy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI